Nephrogenic Adenoma in Patients with Transitional Cell Carcinoma of the Bladder Receiving Intravesical Thiotepa
- 1 January 1988
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 139 (1) , 130-131
- https://doi.org/10.1016/s0022-5347(17)42319-6
Abstract
Nephrogenic adenoma is a rare, benign lesion of the urothelium that generally occurs after open surgery or other bladder trauma. We present 2 recently treated patients with nephrogenic adenomas, both of whom had been treated previously with transurethral resection and intravesical thiotepa for histologically proved transitional cell carcinoma of the bladder. The occurrence of nephrogenic adenoma after transurethral resection alone is extremely rare and suggests a possible adjuvant role of the intravesical thiotepa. With the increasing use of such local chemotherapeutic agents, the incidence of nephrogenic adenoma in such patients may be increasing.Keywords
This publication has 8 references indexed in Scilit:
- Nephrogenic Adenoma Associated with Intravesical Bacillus Calmette-Guerin Treatment: A Report of 2 CasesJournal of Urology, 1986
- Nephrogenic adenomaUrology, 1985
- Nephrogenic Adenoma of Bladder: A Report of 8 CasesJournal of Urology, 1984
- Nephrogenic Adenoma: A Report of 9 Cases and Review of the LiteratureJournal of Urology, 1982
- Nephrogenic adenoma of the urinary bladder and urethraHuman Pathology, 1981
- Nephrogenic Adenoma: a form of Adenomatous Metaplasia of the Bladder. A Clinical and Electron Microscopical StudyBritish Journal of Urology, 1976
- Nephrogenic Metaplasia (Nephrogenic Adenoma, Adenomatoid Tumor) of the BladderJournal of Urology, 1972
- Adenomatoid Tumors of the Bladder Reproducing Renal Structures (Nephrogenic Adenomas)Journal of Urology, 1950